GPRC5A and breast carcinoma: Altogether, DNMT1 inhibits miR-497 and elevates GPRC5A expression through methylation to promote chemotherapy resistance and metastasis in breast cancer (Fig. 7), which sheds a new light on the anti-tumor significance of DNMT1 in regard to breast cancer.